IP Verse

Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T4

Patent No. EP3056187 (titled "Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T4") was filed by Altergon on Nov 13, 2012. The application was issued on Aug 30, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIESMay 17, 2019WIBBELMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3056187

ALTERGON
Application Number
EP16154717A
Filing Date
Nov 13, 2012
Status
Patent Maintained As Amended
Jul 28, 2023
Publication Date
Aug 30, 2023
External Links
Slate, Register , Google Patents